Effects of Saireito, a Japanese herbal medicine, on edema via antagonistic actions against aldosterone in anti-GBM nephritic rats

Springer Science and Business Media LLC - Tập 10 - Trang 13-18 - 2006
Tomohisa Hattori1, Hirofumi Maruyama1, Hiroaki Nishimura1, Yoichiro Nakai1, Iwao Sakakibara1, Yoshio Kase1, Shuichi Takeda1
1Tsumura and Co., Pharmacology Research Department, R&D Division, Ibaraki, Japan

Tóm tắt

In order to clarify the diuretic mechanisms of Saireito, a Japanese herbal medicine, the mineralcorticoid receptor antagonistic action of Saireito was evaluated in anti-glomerular basement membrane (GBM) nephritic rats. Anti-GBM nephritis was induced in rats by the intravenous, injection of anti-GBM serum, and test drugs were administered 5 days after the induction of nephritis. In addition, we also investigated aldosterone-loaded mice to clarify the effects of test drugs on aldosterone signal transduction. In an in vitro study, a mineralocorticoid receptor binding assay of the componets of Saireito was performed. Saireito and spironolactone inhibited the development of proteinuria and abdominal ascites in anti-GBM nephritic rats. Saireito and spironolactone increased the urine volume and decreased the abdominal saline content in aldosterone-loaded mice. Saikosaponin H, a component of Saireito, inhibited the receptor binding of aldosterone in the in vitro assay 50% inhibitory concentration ([IC50], 22 µmol/l). Saikosaponin H also inihibited the decrease in urine volume in aldosterone-loaded mice. These results suggest that the diuretic action of Saireito may be partly due to an antagonistic action on the mineralocorticoid receptor, exerted by saikosaponin H.

Tài liệu tham khảo

N Yoshikawa H Ito T Sakai Y Takekoshi M Honda M Awazu et al. (1997) ArticleTitleA prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group Nippon Jinzo Gakkai Shi (Jpn J Nephrol) 39 503–6 Occurrence Handle1:STN:280:ByiH38fnvF0%3D N Yoshikawa M Ito Y Takekoshi M Honda M Awazu K Iijima et al. (1998) ArticleTitleStandard versus long-term prednisolone with Sairei-to for initial therapy in childhood steroid-responsive nephritic syndrome: a prospective controlled study Nippon Jinzo Gakkai Shi (Jpn J Nephrol) 40 587–90 Occurrence Handle1:STN:280:DyaK1M7gvFegtw%3D%3D T Hattori S Shindo (1995) ArticleTitleEffects of Sairei-to (TJ-114) on the expression of adhesion molecule in anti-GBM nephritic rats Nippon Jinzo Gakkai Shi (Jpn J Nephrol) 37 373–83 Occurrence Handle1:CAS:528:DyaK2MXotVansL4%3D H Kawachi N Takashima M Orikasa T Oite F Shimizu (1994) ArticleTitleEffects of traditional Chinese medicine (Sairei-to) on monoclonal antibody-induced proteinuria in rats Pathol Int 44 339–44 Occurrence Handle1:CAS:528:DyaK2MXitFGmu7k%3D Occurrence Handle8044302 RH Schwinger (1999) ArticleTitleThe aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study Dtsch Med Wochenschr 124 987–8 Occurrence Handle1:STN:280:DyaK1Mvhsl2nug%3D%3D Occurrence Handle10488324 N Farman A Vandewalle JP Bonvalet (1981) ArticleTitleBinding of aldosterone to cytoplasmic and nuclear receptors of the rabbit kidney Am J Physiol 240 C20–7 Occurrence Handle1:CAS:528:DyaL3MXktFKktA%3D%3D Occurrence Handle7457593 Y Suzuki M Ito N Saito (1986) ArticleTitleStudies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin Jpn J Pharmacol 42 465–75 Occurrence Handle1:CAS:528:DyaL2sXktlOhuw%3D%3D Occurrence Handle3027437 ER Blasi R Rocha AE Rudolph EAG Blomme ML Porry EG McMahon (2002) ArticleTitleAldosterone/salt induces renal inflammation and fibrosis in hypertensive rates Kidney Int 63 1791–800 G Wambach J Casals-Stenzel (1983) ArticleTitleStructure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralcorticoid receptors in vitro and the antialdosterone activity in vivo Biochem Pharmacol 32 1479–85 Occurrence Handle10.1016/0006-2952(83)90469-0 Occurrence Handle1:CAS:528:DyaL3sXksVyjsLo%3D Occurrence Handle6222738